🔎 Trials Near Me

Domov › Debelost › Ohio › Cincinnati

Klinične študije za Debelost v Cincinnati, OH

19 študij za Debelost išče udeležence na lokacijah v Cincinnati in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 2
  • CTI Clinical Research Center /ID# 282043, Cincinnati
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Vključevanje udeležencevFaza 2
  • Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Vključevanje udeležencevFaza 3
  • Midwest Eye Center, Cincinnati
  • Velocity Clinical Research, Mt. Auburn, Cincinnati
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Vključevanje udeležencevFaza 3
  • CTI Clinical Research Center, Cincinnati
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • CTI Clinical Research Center, Cincinnati
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3
  • Velocity Clinical Research - Auburn, Cincinnati
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • CTI Clinical Research Center, Cincinnati
Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 3
  • AURORA-1 Clinical Site, Cincinnati
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • AURORA-2 Clinical Site, Cincinnati
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3
  • CTI Clinical Research Center, Cincinnati
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07571005

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3
  • CTI Clinical Research Center, Cincinnati
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • CTI Clinical Research Center, Cincinnati
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Vključevanje udeležencevFaza 3
  • Clinical Trial Investigator Clinical Research Center, Cincinnati
  • Velocity Clinical Research - Cincinnati, Cincinnati
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Vključevanje udeležencevFaza 3
  • Velocity Clinical Research - Cincinnati, Cincinnati
  • Velocity Clinical Research - Springdale, Cincinnati
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Vključevanje udeležencevFaza 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Starost 7–25 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Vključevanje udeležencevFaza 3
  • Lindner Center,Christ Hospital, Cincinnati
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07567001

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
  • Medpace Clinical Pharmacology Unit, Cincinnati
Starost 18–65 · Vsi spoli · Posodobljeno 4. maj 2026 · NCT07219589

Effects of Exercise on Lipids and Endothelial Function in Youth

Vključevanje udeležencev
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Starost 10–20 · Vsi spoli · Posodobljeno 13. feb. 2026 · NCT07409064

A Novel Obesity Prevention Program for High-Risk Infants in Primary Care

Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
  • Hopple Street Neighborhood Health Center, Cincinnati
1 Day · Vsi spoli · Posodobljeno 5. mar. 2025 · NCT06028113

Študije za Debelost v drugih mestih

Druge študije v Cincinnati

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.